Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

tibet-3591529_960_720

Guangdong bans transportation of pigs due to African swine fever outbreak in Hunan

October 23, 2018 Research and Development ASF, African swine fever, China, Guangdong, Hunan, animal health

Chinese authorities have banned the transportation of live pigs from Guangdong to other regions, after reports of African swine fever …
News
roche

Roche’s Alecensa topples Pfizer’s Xalkori in Asian patients with ALK+ advanced lung cancer

October 23, 2018 Manufacturing and Production, Research and Development Alecensa, Cancer, ESMO 2018, Roche, lung cancer, pharma

Following up on the reveal of data concerning its immunotherapy Tecentriq in combination with chemotherapy in the treatment of non-small …
News
merckincweb2

First-line Keytruda shows better overall survival in head & neck cancer

October 23, 2018 Manufacturing and Production, Research and Development Cancer, ESMO 2018, MSD, head and neck cancer, keytruda, pharma

MSD’s Keytruda (pembrolizumab) made an impact at the European Society for Medical Oncology 2018 Congress as the company unveiled new …
News
roche_dark_0

Roche’s Tecentriq+chemo boosts survival in first-line non-small cell lung cancer

October 22, 2018 Research and Development, Sales and Marketing Cancer, Roche, lung cancer NSCLC, pharma, tecentriq

Roche joined other major players like Bristol-Myers Squibb in revealing strong data on their cancer immunotherapies at the European Society …
News

Working Life: Joe Wiley, CEO, Amryt Pharma

October 22, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amryt Pharma, CEO, Ireland, Joe WIley, pharma

Pharmafocus talked to Joe Wiley, CEO and founder of Amryt Pharma as he retraced his journey from medical student in …
Feature
janssen_latest_logo_on_sign_closer

Janssen’s Tremfya maintains skin clearance after 3 years in plaque psoriasis

October 22, 2018 Research and Development, Sales and Marketing Janssen, Tremfya, pharma, plaque psoriasis, psoriasis

Janssen has revealed new long-term data for its IL-23 inhibitor Tremfya (guselkumab) in moderate to severe plaque psoriasis, demonstrating skin …
News
merckincweb

MSD’s Keytruda with Pfizer’s Inlyta beats Sutent in most common kidney cancer

October 19, 2018 Medical Communications, Research and Development Cancer, Kidney cancer, MSD, Pfizer, inlyta, keytruda, pharma

MSD has unveiled new Phase 3 data on its blockbuster anti-PD-1 cancer therapy Keytruda (pembrolizumab) as part of a combination, …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

October 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, AstraZeneca, Bayer, Novartis, Samsung, Trump, biosimilars, brexit

Business, biosimilars and Brexit are the themes of this week’s top 10. While Roche signed a $1 billion deal with …
News
causes_of_hearing_lose_jpg

Hearing loss and inner ear disorders: The next frontier for pharmaceutical success?

October 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sensorion, hearing loss, inner ear disorders, opinion, pharma

Nawal Ouzren, CEO of Sensorion, examines the latest therapies and developments emerging in the difficult-to-treat world of human ear disorders, …
Feature
novartis_window

Novartis snaps up cancer drug developer Endocyte for $2.1 billion

October 18, 2018 Research and Development, Sales and Marketing Cancer, Endocyte, Novartis, pharma

Novartis will shell out $2.1 billion to acquire cancer drug developer Endocyte in a move to leverage the company’s technology …
News
1920px-hiv-budding-color

Researchers launch Phase 1 trial of HIV vaccine

October 18, 2018 Research and Development AIDS, HIV, Vaccine, infection, resdearch

Researchers working with the non-profit organisation the International AIDS Vaccine Initiative (IAVI) have announced the launch of a Phase I …
News

Samsung and Bioepis launch third Humira biosimilar in Europe

October 17, 2018 Research and Development, Sales and Marketing Amgen, Biogen, Humira, Imraldi, Samusng Bioepis, pharma

Hot on the heels of Amgen, Samsung Bioepis and Biogen have announced the launch of their own biosimilar version of …
News
roche_dark_0

Roche signs $1 billion deal with cell therapy firm SQZ biotech

October 17, 2018 Research and Development Roche, SQZ, collaboration, deal, oncology

The Massachusetts-based cell therapy company SQZ Biotech, has announced the expansion of its collaboration with Swiss pharma giant Roche, in …
News

Fewer patents being filed for novel infectious diseases and AMR diagnostic technologies; US leads, UK follows

October 17, 2018 Research and Development AMR, IP, intellectual property, patents

Fewer patents are being filed for point-of-care diagnostic technologies aimed at tackling infectious diseases and antimicrobial resistance (AMR), according to …
News

FDA approves Pfizer’s Talzenna for breast cancer alongside tool to identify eligible patients

October 17, 2018 Research and Development, Sales and Marketing Cancer, FDA, Pfizer, Talzenna, breast cancer, pharma

Pfizer’s Talzenna (talazoparib) has secured FDA approval, it has emerged. The poly (ADP-ribose) polymerase (PARP) inhibitor is now set to …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026